Organoids Market Growth Trajectory Through 2024-2033

Spread the love

The Organoids Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Organoids Market:

https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

According to The Business Research Company’s Organoids Global Market Report 2024, The organoids market size has grown exponentially in recent years. It will grow from $1.42 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate (CAGR) of 25.1%. The growth in the historic period can be attributed to biomedical research advances, drug discovery and development needs, disease modeling requirements, personalized medicine trends, regulatory support..

The organoids market size is expected to see exponential growth in the next few years. It will grow to $4.38 billion in 2028 at a compound annual growth rate (CAGR) of 25.2%. The growth in the forecast period can be attributed to increased prevalence of chronic diseases, advancements in genome editing techniques, rise in stem cell research, collaborations and partnerships, clinical translation efforts.. Major trends in the forecast period include application in regenerative medicine, in vivo imaging techniques, collaborations for multi-organoid systems, ethical and legal considerations, commercialization and market expansion..

An increase in the incidence and prevalence of chronic and infectious diseases is expected to propel the growth of the organoid market going forward. Chronic disease is a condition that lasts more than a year and requires ongoing medical treatment. Organoids have been used to study various chronic diseases and their treatments as they give immediate and dependable information on pathogen biology and drug screening. Hence, the increase in the incidence and prevalence of chronic and infectious diseases will support the organoid market. For instance, in January 2023, according to the National Center for Biotechnology Information, a US-based branch of the National Institutes Of Health, the number of U.S. citizens above the age of 50 with chronic diseases is supposed to increase by approximately 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the rising prevalence of chronic diseases will drive the organoids market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10787&type=smp

The organoids market covered in this report is segmented –

1) By Product: Hepatic Organoid, Colorectal Organoid, Intestinal Organoid, Other Organoid

2) By Source: Pluripotent Stem Cells, Organ-Specific Adult Stem Cells

3) By Application: Developmental Biology, Disease Pathology Of Infectious Disease, Regenerative Medicine, Drug Toxicity And Efficacy Testing, Drug Discovery And Personalized Medicine, Other Applications

4) By End-User: Hospitals And Diagnostic Centers, Biotechnology And Pharmaceutical Companies, Other End-Users

Technological advancements are a key trend gaining popularity in the organoid market. Major companies operating in the organoid market are launching new organoid technologies to sustain their position in the market. For instance, in March 2023, MIMETAS, a Netherlands-based human tissue and disease model developer, launched a new type of adult stem cell (ASC)-derived tubular organoids as a part of the OrganoReady product line. This new organoid uses cutting-edge and innovative technology for mechanistic toxicology and drug-induced organ injury. Organoids are developed as perfused 3D tubular structures with access points on the apical and basal sides using the OrganoPlate, a patented microfluidic platform.

The organoids market report table of contents includes: